login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ALBANY MOLECULAR RESH INC (AMRI) Stock News
NASDAQ:AMRI - Nasdaq -
US0124231095
21.74
0 (0%)
After market: 21.74
0 (0%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AMRI Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Denovo Biopharma LLC
First Patient Dosed in the ENLIGHTEN Biomarker-Guided Global Clinical Trial of DB104 (Liafensine) for Treatment-Resistant Depression
4 years ago - By: Bloomberg
- Mentions:
CG
Carlyle’s Curia in Talks to Buy LakePharma, Integrity Bio
5 years ago - By: Bloomberg
- Mentions:
WLLW.CA
WEED.CA
Race Is On for Synthetic Cannabinoids: Cannabis Weekly
5 years ago - By: Bloomberg
- Mentions:
WLLW.CA
WEED.CA
Race for Artificial Cannabinoids Heats Up: Cannabis Weekly
8 years ago - By: Robbins Geller Rudman & Dowd LLP
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Albany Molecular Research, Inc.
8 years ago - By: The Motley Fool
Why Shares of Control4 Corporation Are Spiking 10% on Its Addition to S&P SmallCap 600
8 years ago - By: 3ST Research
3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)
8 years ago - By: dailystocktracker.com
- Mentions:
ALNY
ALXN
BCRX
Technical Snapshots for These Biotech Stocks -- Alnylam Pharma, Alexion Pharma, Albany Molecular Research, and BioCryst Pharma
8 years ago - By: AMRI
- Mentions:
CG
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR
8 years ago - By: Benzinga
- Mentions:
AMAT
CTIC
MYGN
ROST
...
15 Biggest Mid-Day Gainers For Friday
8 years ago - By: Benzinga
- Mentions:
OPK
AMAT
CTIC
FINL
...
20 Stocks Moving In Friday's Pre-Market Session
8 years ago - By: S&P Dow Jones Indices
- Mentions:
CTRL
SPGI
Control4 Set to Join S&P SmallCap 600
8 years ago - By: Bronstein, Gewirtz & Grossman, LLC
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI)
8 years ago - By: Monteverde & Associates PC
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI
8 years ago - By: Lifshitz & Miller Law Firm
- Mentions:
CCN
COVS
WFM
SAJA
...
Lifshitz & Miller LLP Announces Investigation of Albany Molecular Research, Inc., Atwood Oceanics, Inc., CardConnect Corp., Covisint Corporation, Sajan, Inc., Whole Foods Market, Inc. and Xactly Corporation
8 years ago - By: AMRI
AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI
8 years ago - By: Brower Piven, A Professional Corporation
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information
8 years ago - By: The Law Offices of Vincent Wong
The Law Offices of Vincent Wong Reminds Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group
8 years ago - By: The Law Offices of Vincent Wong
The Law Offices of Vincent Wong Notifies Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group
8 years ago - By: WeissLaw LLP
WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders
8 years ago - By: Harwood Feffer LLP
Harwood Feffer LLP Announces Investigation of Albany Molecular Research, Inc.
8 years ago - By: Brower Piven, A Professional Corporation
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information
8 years ago - By: Levi & Korsinsky, LLP
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders
8 years ago - By: The Briscoe Law Firm, PLLC
Albany Molecular Research, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger with The Carlyle Group
8 years ago - By: Chelmsford Park SA
- Mentions:
ALNY
PRTK
VSTM
Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research
8 years ago - By: Kahn Swick & Foti, LLC
ALBANY MOLECULAR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albany Molecular Research, Inc.
8 years ago - By: Levi & Korsinsky, LLP
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders
Please enable JavaScript to continue using this application.